Test IDs Patients Best Suited for ALK Inhibition Therapy
Researchers have now developed and tested a promising new method for screening ALK fusions in NSCLC.
Read MorePosted by Clinical Lab Products | Dec 13, 2012 | Cancer, Miscellaneous |
Researchers have now developed and tested a promising new method for screening ALK fusions in NSCLC.
Read MorePosted by Judy O'Rourke | Dec 10, 2012 | Cancer, Miscellaneous |
The test detects all types and all stages of lung cancer, including Stage I and II.
Read MorePosted by Judy O'Rourke | Dec 10, 2012 | Cancer, Miscellaneous |
Ronnie Andrews, Life Technologies’ president of medical sciences, has shepherded multiple acquisitions and product launches as Life continues to expand its presence in the world of clinical diagnostics. Here he looks back at 2012, and ahead to 2013.
Read MorePosted by Judy O'Rourke | Dec 6, 2012 | Molecular Diagnostics |
State-of-the-art medical research institute will bring new hope to young patients facing life-threatening diseases with sophisticated genomic analysis and real-time access to drugs.
Read MorePosted by Judy O'Rourke | Nov 29, 2012 | Information Technology, Lab Automation, Middleware & Software, Molecular Diagnostics |
Automated scans of FISH test slides of lung cancer cells preserve results, and enhance objectivity.
Read More